2025 CPT code 90732

Administration of a 23-valent pneumococcal polysaccharide vaccine (PPSV23) to individuals 2 years or older via intramuscular or subcutaneous injection.

Follow all applicable CPT coding guidelines for vaccine administration.Remember to bill separately for the vaccine product and its administration.

Modifiers may be applicable depending on circumstances (e.g., place of service, different physicians involved). Consult your payer's guidelines for specific modifier requirements.

Medical necessity is established based on the patient's age and/or medical condition that increases their risk of pneumococcal disease (e.g., age ≥65, immunocompromised status, chronic lung disease).The physician's assessment and documentation must justify the administration of the vaccine.

The physician or qualified healthcare professional must ensure the patient is appropriately screened and counselled about risks and benefits before administering the vaccine. The administration itself involves preparing the injection site and giving the intramuscular or subcutaneous injection.

IMPORTANT Code 90670 is used for the administration of the 13-valent pneumococcal conjugate vaccine (PCV13).Separate codes are required for the vaccine product itself (e.g., from the 90476-90759 range) and for the administration.

In simple words: This code covers the injection of a pneumonia vaccine (PPSV23) given to people age 2 and older.The doctor gives the shot in the muscle or under the skin.This is just for giving the shot, not for the vaccine itself.

This CPT code, 90732, represents the administration of a 23-valent pneumococcal polysaccharide vaccine (PPSV23) to patients aged 2 years or older.The vaccine is injected either intramuscularly or subcutaneously.The code does not include the cost of the vaccine itself; that is reported separately using a product code from the 90476-90759 range.Appropriate documentation must support the administration, including patient age, vaccine type, and injection site.

Example 1: A 67-year-old patient presents for their annual flu shot and requests a pneumococcal vaccine. The physician administers PPSV23 intramuscularly and bills for both the administration (90732) and the product code (from the 90476-90759 range). , A 3-year-old child with sickle cell anemia receives a PPSV23 injection as part of their preventative care. The appropriate vaccine product code and 90732 are billed. The medical record must detail the underlying condition to support medical necessity., A 25-year-old immunocompromised patient receives PPSV23 subcutaneously.Documentation should include the reason for immunosuppression and the physician's rationale for administering the vaccine.

* Patient age* Vaccine administered (PPSV23)* Route of administration (intramuscular or subcutaneous)* Site of injection* Date of administration* Indication for vaccination (e.g., age, immunocompromised status)* Patient's medical history relevant to the vaccination (e.g., allergies)* Any adverse reactions

** Always refer to the most current CPT and payer guidelines for the most accurate coding and billing practices.

  • Revenue Code: O1G (Influenza Immunization - this is a placeholder,the actual revenue code may vary depending on payer and other factors)
  • RVU: This information is not provided in the source. Refer to the most up-to-date RVU data for your payer.
  • Global Days : Not applicable; this is not a surgical procedure.
  • Payment Status: Active
  • Modifier TC rule: Not applicable. The code encompasses the entire service.
  • Fee Schedule : Refer to your payer's historical fee schedule for pricing data.
  • Specialties:Infectious Disease, Internal Medicine, Family Medicine, Geriatrics, Pulmonology
  • Place of Service:Office, Outpatient Hospital, Inpatient Hospital, other settings as per payer guidelines
** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.